Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 990 entries
Sorted by: Best Match Show Resources per page
Corrigendum to 'Ca.

Cancer letters

Chai S, Qian Y, Tang J, Liang Z, Zhang M, Si J, Li X, Huang W, Xu R, Wang K.
PMID: 27491000
Cancer Lett. 2016 Oct 01;380(2):609-610. doi: 10.1016/j.canlet.2016.07.026. Epub 2016 Aug 01.

No abstract available.

Cite
Chai S, Qian Y, Tang J, et al. Corrigendum to 'Ca. Cancer Lett. 2016;380(2):609-610doi: 10.1016/j.canlet.2016.07.026.
Chai, S., Qian, Y., Tang, J., Liang, Z., Zhang, M., Si, J., Li, X., Huang, W., Xu, R., & Wang, K. (2016). Corrigendum to 'Ca. Cancer letters, 380(2), 609-610. https://doi.org/10.1016/j.canlet.2016.07.026
Chai, Shoujie, et al. "Corrigendum to 'Ca." Cancer letters vol. 380,2 (2016): 609-610. doi: https://doi.org/10.1016/j.canlet.2016.07.026
Chai S, Qian Y, Tang J, Liang Z, Zhang M, Si J, Li X, Huang W, Xu R, Wang K. Corrigendum to 'Ca. Cancer Lett. 2016 Oct 01;380(2):609-610. doi: 10.1016/j.canlet.2016.07.026. Epub 2016 Aug 01. PMID: 27491000.
Copy Download .nbib Format: NLM
RE: Cancer incidence and mortality in China, 2013 by Chen et al.

Cancer letters

Yu XQ, Baade P.
PMID: 28455247
Cancer Lett. 2017 Aug 10;401:72-73. doi: 10.1016/j.canlet.2017.04.018. Epub 2017 Apr 25.

No abstract available.

Cite
Yu XQ, Baade P. RE: Cancer incidence and mortality in China, 2013 by Chen et al. Cancer Lett. 2017;401:72-73doi: 10.1016/j.canlet.2017.04.018.
Yu, X. Q., & Baade, P. (2017). RE: Cancer incidence and mortality in China, 2013 by Chen et al. Cancer letters, 40172-73. https://doi.org/10.1016/j.canlet.2017.04.018
Yu, Xue Qin, and Baade, Peter. "RE: Cancer incidence and mortality in China, 2013 by Chen et al." Cancer letters vol. 401 (2017): 72-73. doi: https://doi.org/10.1016/j.canlet.2017.04.018
Yu XQ, Baade P. RE: Cancer incidence and mortality in China, 2013 by Chen et al. Cancer Lett. 2017 Aug 10;401:72-73. doi: 10.1016/j.canlet.2017.04.018. Epub 2017 Apr 25. PMID: 28455247.
Copy Download .nbib Format: NLM
Use of indocyanine green for detecting sentinel lymph nodes in breast cancer: letter to the editor.

World journal of surgical oncology

Hidar S.
PMID: 28347307
World J Surg Oncol. 2017 Mar 27;15(1):70. doi: 10.1186/s12957-017-1138-z.

In a previous issue of the journal, Oldřich Coufal and Vuk Fait reported a pilot study that specifically addressed the use of indocyanine green for detecting sentinel lymph nodes in breast cancer within a European population. They concluded that...

Cite
Hidar S. Use of indocyanine green for detecting sentinel lymph nodes in breast cancer: letter to the editor. World J Surg Oncol. 2017;15(1):70doi: 10.1186/s12957-017-1138-z.
Hidar, S. (2017). Use of indocyanine green for detecting sentinel lymph nodes in breast cancer: letter to the editor. World journal of surgical oncology, 15(1), 70. https://doi.org/10.1186/s12957-017-1138-z
Hidar, Samir. "Use of indocyanine green for detecting sentinel lymph nodes in breast cancer: letter to the editor." World journal of surgical oncology vol. 15,1 (2017): 70. doi: https://doi.org/10.1186/s12957-017-1138-z
Hidar S. Use of indocyanine green for detecting sentinel lymph nodes in breast cancer: letter to the editor. World J Surg Oncol. 2017 Mar 27;15(1):70. doi: 10.1186/s12957-017-1138-z. PMID: 28347307; PMCID: PMC5368913.
Copy Download .nbib Format: NLM
O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents.

Oncology reports

Badawi A.
PMID: 21607486
Oncol Rep. 1994 Sep;1(5):1023-7. doi: 10.3892/or.1.5.1023.

The activity of O-6-alkylguanine-DNA alkyl transferase (ATase), the enzyme responsible for repairing promutagenic methylation damage in DNA, was measured at various time intervals in tissue extracts of mice administered (in vivo) a single therapeutic dose of the antischistosomal agents...

Cite
Badawi A. O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents. Oncol Rep. 1994;1(5):1023-7doi: 10.3892/or.1.5.1023.
Badawi, A. (1994). O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents. Oncology reports, 1(5), 1023-7. https://doi.org/10.3892/or.1.5.1023
Badawi, A. "O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents." Oncology reports vol. 1,5 (1994): 1023-7. doi: https://doi.org/10.3892/or.1.5.1023
Badawi A. O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents. Oncol Rep. 1994 Sep;1(5):1023-7. doi: 10.3892/or.1.5.1023. PMID: 21607486.
Copy Download .nbib Format: NLM
The role played by the microenvironment in site-specific metastasis.

Cancer letters

Klein-Goldberg A, Maman S, Witz IP.
PMID: 23988268
Cancer Lett. 2014 Sep 28;352(1):54-8. doi: 10.1016/j.canlet.2013.08.029. Epub 2013 Aug 27.

Cancer cells that disseminate to metastatic sites may progress to frank metastasis or persist as dormant micrometastasis. Significant progress has been made in defining the genetic and phenotypic cancer-cell-autonomous determinants of metastasis and in the understanding of the cross-talk...

Cite
Klein-Goldberg A, Maman S, Witz IP. The role played by the microenvironment in site-specific metastasis. Cancer Lett. 2013;352(1):54-8doi: 10.1016/j.canlet.2013.08.029.
Klein-Goldberg, A., Maman, S., & Witz, I. P. (2014). The role played by the microenvironment in site-specific metastasis. Cancer letters, 352(1), 54-8. https://doi.org/10.1016/j.canlet.2013.08.029
Klein-Goldberg, Anat, et al. "The role played by the microenvironment in site-specific metastasis." Cancer letters vol. 352,1 (2014): 54-8. doi: https://doi.org/10.1016/j.canlet.2013.08.029
Klein-Goldberg A, Maman S, Witz IP. The role played by the microenvironment in site-specific metastasis. Cancer Lett. 2014 Sep 28;352(1):54-8. doi: 10.1016/j.canlet.2013.08.029. Epub 2013 Aug 27. PMID: 23988268.
Copy Download .nbib Format: NLM
WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.

Cancer letters

Yadav VR, Prasad S, Reuter S, Sung B, Yamamoto N, Murakami A, Aggarwal BB.
PMID: 22182452
Cancer Lett. 2011 Dec 17; doi: 10.1016/j.canlet.2011.12.011. Epub 2011 Dec 17.

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Cite
Yadav VR, Prasad S, Reuter S, et al. WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand. Cancer Lett. 2011;doi: 10.1016/j.canlet.2011.12.011.
Yadav, V. R., Prasad, S., Reuter, S., Sung, B., Yamamoto, N., Murakami, A., & Aggarwal, B. B. (2011). WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand. Cancer letters, . https://doi.org/10.1016/j.canlet.2011.12.011
Yadav, Vivek R, et al. "WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand." Cancer letters vol. (2011). doi: https://doi.org/10.1016/j.canlet.2011.12.011
Yadav VR, Prasad S, Reuter S, Sung B, Yamamoto N, Murakami A, Aggarwal BB. WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand. Cancer Lett. 2011 Dec 17; doi: 10.1016/j.canlet.2011.12.011. Epub 2011 Dec 17. PMID: 22182452; PMCID: PMC3769506.
Copy Download .nbib Format: NLM
Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181].

Cancer letters

Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH.
PMID: 29277381
Cancer Lett. 2018 Feb 01;414:313. doi: 10.1016/j.canlet.2017.11.030.

No abstract available.

Cite
Ali S, Ahmad A, Aboukameel A, et al. Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181]. Cancer Lett. 2018;414:313doi: 10.1016/j.canlet.2017.11.030.
Ali, S., Ahmad, A., Aboukameel, A., Bao, B., Padhye, S., Philip, P. A., & Sarkar, F. H. (2018). Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181]. Cancer letters, 414313. https://doi.org/10.1016/j.canlet.2017.11.030
Ali, Shadan, et al. "Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181]." Cancer letters vol. 414 (2018): 313. doi: https://doi.org/10.1016/j.canlet.2017.11.030
Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181]. Cancer Lett. 2018 Feb 01;414:313. doi: 10.1016/j.canlet.2017.11.030. PMID: 29277381; PMCID: PMC5991481.
Copy Download .nbib Format: NLM
Corrigendum to 'Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells' [Cancer letters, 2013, 330(1): 49-56].

Cancer letters

Shao J, Dai Y, Zhao W, Xie J, Xue J, Ye J, Jia L.
PMID: 29550170
Cancer Lett. 2018 May 28;422:129-130. doi: 10.1016/j.canlet.2018.03.001. Epub 2018 Mar 15.

No abstract available.

Cite
Shao J, Dai Y, Zhao W, et al. Corrigendum to 'Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells' [Cancer letters, 2013, 330(1): 49-56]. Cancer Lett. 2018;422:129-130doi: 10.1016/j.canlet.2018.03.001.
Shao, J., Dai, Y., Zhao, W., Xie, J., Xue, J., Ye, J., & Jia, L. (2018). Corrigendum to 'Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells' [Cancer letters, 2013, 330(1): 49-56]. Cancer letters, 422129-130. https://doi.org/10.1016/j.canlet.2018.03.001
Shao, Jingwei, et al. "Corrigendum to 'Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells' [Cancer letters, 2013, 330(1): 49-56]." Cancer letters vol. 422 (2018): 129-130. doi: https://doi.org/10.1016/j.canlet.2018.03.001
Shao J, Dai Y, Zhao W, Xie J, Xue J, Ye J, Jia L. Corrigendum to 'Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells' [Cancer letters, 2013, 330(1): 49-56]. Cancer Lett. 2018 May 28;422:129-130. doi: 10.1016/j.canlet.2018.03.001. Epub 2018 Mar 15. PMID: 29550170.
Copy Download .nbib Format: NLM
Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281].

Cancer letters

Tu M, Lu C, Lv N, Wei J, Lu Z, Xi C, Chen J, Guo F, Jiang K, Li Q, Wu J, Song G, Wang S, Gao W, Miao Y.
PMID: 30594325
Cancer Lett. 2019 Mar 01;444:189-190. doi: 10.1016/j.canlet.2018.12.002. Epub 2018 Dec 26.

No abstract available.

Cite
Tu M, Lu C, Lv N, et al. Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281]. Cancer Lett. 2018;444:189-190doi: 10.1016/j.canlet.2018.12.002.
Tu, M., Lu, C., Lv, N., Wei, J., Lu, Z., Xi, C., Chen, J., Guo, F., Jiang, K., Li, Q., Wu, J., Song, G., Wang, S., Gao, W., & Miao, Y. (2019). Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281]. Cancer letters, 444189-190. https://doi.org/10.1016/j.canlet.2018.12.002
Tu, Min, et al. "Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281]." Cancer letters vol. 444 (2019): 189-190. doi: https://doi.org/10.1016/j.canlet.2018.12.002
Tu M, Lu C, Lv N, Wei J, Lu Z, Xi C, Chen J, Guo F, Jiang K, Li Q, Wu J, Song G, Wang S, Gao W, Miao Y. Corrigendum to 'Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2' [Cancer Lett. 2016 Dec 28; 383 (2):272-281]. Cancer Lett. 2019 Mar 01;444:189-190. doi: 10.1016/j.canlet.2018.12.002. Epub 2018 Dec 26. PMID: 30594325.
Copy Download .nbib Format: NLM
Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36].

Cancer letters

Manu KA, Shanmugam MK, Ramachandran L, Li F, Siveen KS, Chinnathambi A, Zayed ME, Alharbi SA, Arfuso F, Kumar AP, Ahn KS, Sethi G.
PMID: 29338890
Cancer Lett. 2018 Apr 28;420:259. doi: 10.1016/j.canlet.2018.01.003. Epub 2018 Jan 17.

No abstract available.

Cite
Manu KA, Shanmugam MK, Ramachandran L, et al. Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]. Cancer Lett. 2018;420:259doi: 10.1016/j.canlet.2018.01.003.
Manu, K. A., Shanmugam, M. K., Ramachandran, L., Li, F., Siveen, K. S., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Arfuso, F., Kumar, A. P., Ahn, K. S., & Sethi, G. (2018). Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]. Cancer letters, 420259. https://doi.org/10.1016/j.canlet.2018.01.003
Manu, Kanjoormana A, et al. "Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]." Cancer letters vol. 420 (2018): 259. doi: https://doi.org/10.1016/j.canlet.2018.01.003
Manu KA, Shanmugam MK, Ramachandran L, Li F, Siveen KS, Chinnathambi A, Zayed ME, Alharbi SA, Arfuso F, Kumar AP, Ahn KS, Sethi G. Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36]. Cancer Lett. 2018 Apr 28;420:259. doi: 10.1016/j.canlet.2018.01.003. Epub 2018 Jan 17. PMID: 29338890.
Copy Download .nbib Format: NLM
Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].

Cancer letters

Lu YX, Ju HQ, Wang F, Chen LZ, Wu QN, Sheng H, Mo HY, Pan ZZ, Xie D, Kang TB, Chen G, Yun JP, Zeng ZL, Xu RH.
PMID: 31623877
Cancer Lett. 2020 Jan 28;469:526. doi: 10.1016/j.canlet.2019.10.001. Epub 2019 Oct 14.

No abstract available.

Cite
Lu YX, Ju HQ, Wang F, et al. Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97]. Cancer Lett. 2019;469:526doi: 10.1016/j.canlet.2019.10.001.
Lu, Y. X., Ju, H. Q., Wang, F., Chen, L. Z., Wu, Q. N., Sheng, H., Mo, H. Y., Pan, Z. Z., Xie, D., Kang, T. B., Chen, G., Yun, J. P., Zeng, Z. L., & Xu, R. H. (2020). Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97]. Cancer letters, 469526. https://doi.org/10.1016/j.canlet.2019.10.001
Lu, Yun-Xin, et al. "Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97]." Cancer letters vol. 469 (2020): 526. doi: https://doi.org/10.1016/j.canlet.2019.10.001
Lu YX, Ju HQ, Wang F, Chen LZ, Wu QN, Sheng H, Mo HY, Pan ZZ, Xie D, Kang TB, Chen G, Yun JP, Zeng ZL, Xu RH. Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97]. Cancer Lett. 2020 Jan 28;469:526. doi: 10.1016/j.canlet.2019.10.001. Epub 2019 Oct 14. PMID: 31623877.
Copy Download .nbib Format: NLM
Retraction notice to "Sun exposure related methylation in malignant and non-malignant skin lesions" [Cancer Letters 245/1-2 (2007) 112-120].

Cancer letters

Sathyanarayana UG, Moore AY, Li L, Padar A, Majmudar K, Stastny V, Makarla P, Suzuki M, Minna JD, Feng Z, Gazdar AF.
PMID: 30007586
Cancer Lett. 2018 Sep 28;432:272. doi: 10.1016/j.canlet.2018.07.010.

No abstract available.

Cite
Sathyanarayana UG, Moore AY, Li L, et al. Retraction notice to "Sun exposure related methylation in malignant and non-malignant skin lesions" [Cancer Letters 245/1-2 (2007) 112-120]. Cancer Lett. 2018;432:272doi: 10.1016/j.canlet.2018.07.010.
Sathyanarayana, U. G., Moore, A. Y., Li, L., Padar, A., Majmudar, K., Stastny, V., Makarla, P., Suzuki, M., Minna, J. D., Feng, Z., & Gazdar, A. F. (2018). Retraction notice to "Sun exposure related methylation in malignant and non-malignant skin lesions" [Cancer Letters 245/1-2 (2007) 112-120]. Cancer letters, 432272. https://doi.org/10.1016/j.canlet.2018.07.010
Sathyanarayana, Ubaradka G, et al. "Retraction notice to "Sun exposure related methylation in malignant and non-malignant skin lesions" [Cancer Letters 245/1-2 (2007) 112-120]." Cancer letters vol. 432 (2018): 272. doi: https://doi.org/10.1016/j.canlet.2018.07.010
Sathyanarayana UG, Moore AY, Li L, Padar A, Majmudar K, Stastny V, Makarla P, Suzuki M, Minna JD, Feng Z, Gazdar AF. Retraction notice to "Sun exposure related methylation in malignant and non-malignant skin lesions" [Cancer Letters 245/1-2 (2007) 112-120]. Cancer Lett. 2018 Sep 28;432:272. doi: 10.1016/j.canlet.2018.07.010. PMID: 30007586.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 990 entries